New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 6, 2013
08:53 EDTCVS, WAG, ESRXCVS says on track to deliver significant cost savings from streamlining efforts
Says expects to hit full run rate of annual savings of $225M-$275M beginning in 2014. Says working with CMS to resolve Medicare Part D sanction; says SilverScript members not affected by this action. In 2013, says expects to retain at least 60% of the scripts gained during the Walgreens (WAG)/Express Scripts (ESRX) impasse. Says will continue to take a "measured approach" to international growth plan. Comments made on the Q4 earnings conference call.
News For CVS;WAG;ESRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
September 30, 2014
07:45 EDTCVSJMP Securities to hold a conference
Subscribe for More Information
07:37 EDTWAGWalgreen targeting cost savings of $1B by FY17
Subscribe for More Information
07:36 EDTWAGWalgreen sees FY15 synergies with Alliance Boots $650M
Walgreen reports combined FY14 synergies with Alliance Boots reached $491M. FY15 synergies are expected to be approximately $650M. The company opened or acquired 46 new drugstores in Q4, compared with 33 in the year-ago quarter. In FY14, Walgreens added a net gain of 21 new drugstores in addition to 70 net new drugstores through acquisitions. At Aug. 31, Walgreens operated 8,309 locations.
07:32 EDTWAGWalgreen reports Q4 adjusted EPS 74c, consensus 74c
Subscribe for More Information
September 29, 2014
15:34 EDTWAGWalgreen technical comments ahead of earnings
The shares have broadly underperformed the averages in the last three months, trading down over 19%. The trend was moderately down until a large gap down in share price in early August. Since then the shares have traded in a relatively narrow range defined largely by a low at $60 and a high at $65. Ahead of earnings the shares have edged below that $60 level. If the news is worse than already low expectations, the $60 area will be one to watch. A continued slide in share price below $60 would see supports as potential downside objectives at $57.75, $53.76 which is the 52-week low, and $50.33 on an extreme move on a large disappointment. If the news exceeds low expectations, there would be room for a snap-back rally. Resistance levels which could become upside objectives are at $62.49, $65.19, and $66.50. The latter level is the top of the bearish gap from early August. A bullish filling of that gap would be bullish for future price.
15:11 EDTWAGNotable companies reporting before tomorrow's open
Subscribe for More Information
10:23 EDTWAGWalgreen October weekly volatility increases into Q4 and outlook
Subscribe for More Information
06:38 EDTWAGWalgreen says court preliminarily approves shareholder settlement
Walgreen said in a filling on Friday that on September 19, the United States District Court for the Northern District of Illinois, Eastern Division, issued an order preliminarily approving a proposed settlement by and among Walgreen Co, the plaintiffs, and all named individual defendants in the shareholder derivative action entitled In re Walgreen Co. Derivative Litigation, No. 13-05471. The proposed settlement implements the agreement in principle reflected in the settlement term sheet executed by the parties in June 2014, as previously disclosed in the Companyís Form 10-Q for the fiscal quarter ended May 31, 2014.A hearing to determine whether the court should issue an order of final approval of the settlement has been scheduled for December 9, 2014, at 11:15 a.m. in Courtroom 1925 at the United States District Court for the Northern District of Illinois, Eastern Division, Everett McKinley Dirksen United States Courthouse, 219 South Dearborn Street, Chicago, Illinois, 60604. Pursuant to the courtís order, any objections to the settlement must be filed in writing with the court by no later than November 25, 2014. Additional information concerning the terms of the proposed settlement, the December 9, 2014 hearing, and the requirements for objections can be found in the Notice of Pendency and Settlement of Shareholder Derivative Action.
September 26, 2014
15:46 EDTWAGOptions expected to be active next week
Subscribe for More Information
13:53 EDTCVSCVS' Caremark to pay $6M to settle false claims allegations
Subscribe for More Information
September 25, 2014
10:06 EDTCVSCVS Health management to meet with Leerink
Meeting to be held in Los Angeles on October 1 hosted by Leerink.
September 24, 2014
14:16 EDTWAGWalgreen October weekly volatility elevated into Q4 and revenue outlook
Subscribe for More Information
08:33 EDTCVSCVS Health enters into clinical affilitation with three academic medical centers
CVS Health has entered into new clinical affiliations with three leading academic medical centers. The collaborating medical centers include the University of Maryland Medical System, University of Texas Medical Branch at Galveston, and the University of Alabama at Birmingham Health System. Through these clinical affiliations the patients served by these medical centers will continue to have access to clinical support, medication counseling, chronic disease monitoring and wellness programs at CVS/pharmacy stores and MinuteClinic, the retail medical clinic division of CVS Health.
06:50 EDTWAGWalgreen mulls infusion division sale deal, Reuters says
Subscribe for More Information
September 23, 2014
10:33 EDTCVSCVS Health management to meet with Wolfe Research
Subscribe for More Information
September 22, 2014
10:15 EDTWAGOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Actavis (ACT) downgraded to Equal Weight from Overweight at Barclays... Aetna (AET) downgraded to Neutral from Buy at BofA/Merrill... Auxilium (AUXL) downgraded to Hold from Buy at Stifel... CARBO Ceramics (CRR) downgraded to Neutral from Buy at Sterne Agee... Commerzbank (CRZBY) downgraded to Underperform from Neutral at Exane BNP Paribas... Concur (CNQR) downgraded to Neutral from Buy at Nomura... Dresser-Rand (DRC) downgraded to Neutral from Accumulate at Global Hunter... Finish Line (FINL) downgraded to Equal Weight from Overweight at Morgan Stanley... General Communications (GNCMA) downgraded to Hold from Buy at Drexel Hamilton... InvenSense (INVN) downgraded to Neutral from Outperform at RW Baird... Las Vegas Sands (LVS) downgraded to Market Perform from Outperform at Wells Fargo... Lindsay Corp. (LNN) downgraded at Sterne Agee... Melco Crown (MPEL) downgraded to Market Perform from Outperform at Wells Fargo... Outerwall (OUTR) downgraded to Sell from Neutral at B. Riley... PSEG (PEG) downgraded to Hold from Buy at Jefferies... Realogy (RLGY) downgraded to Underperform from Neutral at Credit Suisse... Regal-Beloit (RBC) downgraded to Accumulate from Buy at Global Hunter... SABMiller (SBMRY) downgraded to Market Perform from Outperform at Bernstein... Saba Software (SABA) downgraded to Neutral from Buy at B. Riley... Suburban Propane (SPH) downgraded to Market Perform from Outperform at Wells Fargo... Swiss Re (SSREY) downgraded to Underperform from Neutral at Exane BNP Paribas... Towers Watson (TW) downgraded to Buy from Conviction Buy at Goldman... Valmont (VMI) downgraded at Sterne Agee... Walgreen (WAG) downgraded to Equal Weight from Overweight at Barclays... Watts Water (WTS) downgraded to Neutral from Buy at Janney Capital... Wynn Resorts (WYNN) downgraded to Market Perform from Outperform at Wells Fargo... Yahoo (YHOO) downgraded to Neutral from Buy at BofA/Merrill.
05:55 EDTWAGWalgreen downgraded to Equal Weight from Overweight at Barclays
Subscribe for More Information
September 19, 2014
07:22 EDTCVSNational Press Club holds a luncheon meeting
Subscribe for More Information
September 18, 2014
11:55 EDTCVS, WAGRite Aid falls as drugstore chain trims FY15 view
Subscribe for More Information
September 16, 2014
08:12 EDTWAGWalgreen files S-4, prospectus for strategic transaction with Alliance Boots
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use